a public good project by the
Synthesis
Company
of California

© 2026

Yu‐Pei Chen | doi.page

0 works0 citations0 h-index

Yu‐Pei Chen

Sun Yat-sen University(CN)Sun Yat-sen University Cancer Center(CN)

Publications by Year

Research Areas

Head and Neck Cancer Studies, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Head and Neck Surgical Oncology, Lung Cancer Research Studies

Most-Cited Works

→ Nasopharyngeal carcinoma(2019)2,981 cited
→ Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma(2019)909 cited
→ Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis(2018)565 cited
→ Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma(2020)468 cited
→ The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma(2021)384 cited
→ Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline(2021)379 cited

→ Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy(2018)

303 cited

→ Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications(2017)244 cited

→ Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial(2021)226 cited

→ Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era(2017)197 cited